Essential Pharmaceuticals is a trusted brand that has been dedicated to the transplant community since 2006. With a strong focus on transplant medicine, Essential Pharmaceuticals provides high-quality products, exceptional service, and valuable contributions to the field. One of their flagship products is Custodiol® HTK, a cutting-edge organ preservation solution that has emerged as a top choice in the United States.

Since its inception in 2000, Custodiol® HTK has been a vital component of Essential Pharmaceuticals' portfolio, becoming a cornerstone of their success. Over the years, Essential Pharmaceuticals has grown into a specialized and reputable business, boasting a skilled sales, customer service, and marketing team. In 2017, Essential Pharmaceuticals was acquired by Accord Healthcare, further solidifying its position in the industry.

As part of this collaboration, Accord gained the rights to distribute Custodiol® HTK Solution in the United States and Canada. With a commitment to excellence and innovation, Essential Pharmaceuticals continues to shape the future of transplant medicine